Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 8:56 PM
Study NCT ID:
NCT07359027
Status:
COMPLETED
Last Update Posted:
2026-01-26
First Post:
2022-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease
Sponsor:
Second Xiangya Hospital of Central South University
Organization:
Study Overview
Official Title:
Clinical Observation of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease (Stage III-IV)
Status:
COMPLETED
Status Verified Date:
2026-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a single-arm, open-label, multicenter and prospective study, which is conducted to evaluate the effect of Roxadustat on anemia in subjects with DKD (stage III-IV).
Detailed Description:
This study will consist of three study periods as follows:
Screening Period: 2 weeks Treatment Period: 24weeks Follow-up Period: 4 weeks
Screening Period: 2 weeks Treatment Period: 24weeks Follow-up Period: 4 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: